Europe's Vaccine Rollout: Unity and Challenges

This chapter explores the deployment of the Pfizer-BioNTech vaccine across Europe, focusing on the EU's centralized purchasing strategy and the challenges of coordinating distribution among member states. While the rollout faced initial delays compared to other regions, it reflects a unified effort to inoculate the population amidst vaccine skepticism and logistical hurdles. The discussion also considers the implications for future EU healthcare coordination in light of the pandemic's challenges.